- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic strategies to overcome taxane resistance in cancer
Authors
Keywords
Cancer, Multidrug resistance (MDR), Taxanes, Paclitaxel (PTX), Docetaxel, Apoptotic proteins, Tumor-suppressor proteins, Microtubule disruptors, Nano-delivery systems, Natural products, Anticancer drugs
Journal
DRUG RESISTANCE UPDATES
Volume 55, Issue -, Pages 100754
Publisher
Elsevier BV
Online
2021-02-27
DOI
10.1016/j.drup.2021.100754
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
- (2021) Jing-Quan Wang et al. DRUG RESISTANCE UPDATES
- Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
- (2021) Luciana Mosca et al. DRUG RESISTANCE UPDATES
- Phenolic Composition, Antioxidant Capacity and Antibacterial Activity of White Wormwood (Artemisia herba-alba)
- (2021) Muthanna J. Mohammed et al. Plants-Basel
- Natural Product as Substrates of ABC Transporters: A Review
- (2021) Xuan-Yu Chen et al. Recent Patents on Anti-Cancer Drug Discovery
- A Combined Bioinformatic and Nanoparticle-Based Study Reveal the Role of ABCG2 in the Resistance of Breast Cancer
- (2021) Qin Huo et al. Recent Patents on Anti-Cancer Drug Discovery
- Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action
- (2020) Qian Liu et al. Aging-US
- Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
- (2020) Jinyun Dong et al. DRUG RESISTANCE UPDATES
- The tubulin code and its role in controlling microtubule properties and functions
- (2020) Carsten Janke et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years
- (2020) Hongyu Tao et al. Recent Patents on Anti-Cancer Drug Discovery
- Toward a Personalized Use of Paclitaxel
- (2020) Gian L. Russo Recent Patents on Anti-Cancer Drug Discovery
- Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature’s Bounty
- (2020) Mohammad Arif Ashraf Biomed Research International
- Perplexing Role of P-Glycoprotein in Tumor Microenvironment
- (2020) Kianna Robinson et al. Frontiers in Oncology
- Chemotherapeutic Efficacy Enhancement in P-gp-Overexpressing Cancer Cells by Flavonoid-Loaded Polymeric Micelles
- (2020) Ruttiros Khonkarn et al. AAPS PHARMSCITECH
- Overcoming the hypoxia-induced drug resistance in liver tumor by the concurrent use of apigenin and paclitaxel
- (2020) Ke Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nanomedicine to target multidrug resistant tumors
- (2020) Elise Lepeltier et al. DRUG RESISTANCE UPDATES
- Microtubule-targeting agents and their impact on cancer treatment
- (2020) Vladimír Čermák et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Mechanisms of Multidrug Resistance in Cancer Chemotherapy
- (2020) Karol Bukowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance
- (2020) Ping Zhong et al. MOLECULAR PHARMACEUTICS
- Targeting apoptosis in cancer therapy
- (2020) Benedito A. Carneiro et al. Nature Reviews Clinical Oncology
- A review on antimicrobial botanicals, phytochemicals and natural resistance modifying agents from Apocynaceae family: Possible therapeutic approaches against multidrug resistance in pathogenic microorganisms
- (2020) Uttpal Anand et al. DRUG RESISTANCE UPDATES
- Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators
- (2020) Bruno M. F. Gonçalves et al. MOLECULES
- Beyond the Paclitaxel and Vinca Alkaloids: Next Generation of Plant-Derived Microtubule-Targeting Agents with Potential Anticancer Activity
- (2020) Dangquan Zhang et al. Cancers
- Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance
- (2020) Nir Shahar et al. DRUG RESISTANCE UPDATES
- Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
- (2020) Hang Zhang et al. MEDICINAL RESEARCH REVIEWS
- Recent Advances in Development of Selective Mcl-1 Inhibitors for Treatment of Cancer (2017-Present)
- (2020) Ying Fan et al. Recent Patents on Anti-Cancer Drug Discovery
- Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
- (2020) Bowen Li et al. DRUG RESISTANCE UPDATES
- Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds
- (2019) Darinka Gjorgieva Ackova et al. Recent Patents on Anti-Cancer Drug Discovery
- Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression
- (2019) Koji Nakamura et al. Oncotarget
- Plant-derived Edible Nanoparticles and miRNAs: Emerging Frontier for Therapeutics and Targeted Drug-delivery
- (2019) Siavash Iravani et al. ACS Sustainable Chemistry & Engineering
- FOXM1 Deubiquitination by USP21 Regulates Cell Cycle Progression and Paclitaxel Sensitivity in Basal-like Breast Cancer
- (2019) Anthony Arceci et al. Cell Reports
- BCL-2 family isoforms in apoptosis and cancer
- (2019) Chloe F. A. Warren et al. Cell Death & Disease
- 10-Phenyltriazoyl artemisinin is a novel P-glycoprotein inhibitor that suppresses the overexpression and function of P-glycoprotein
- (2019) Dong-Hwan Lee et al. CURRENT PHARMACEUTICAL DESIGN
- Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer
- (2019) Cornelia Schroeder et al. BMC CANCER
- FoxM1 Induced Paclitaxel Resistance via Activation of FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of ABCA2 Transporter
- (2019) Chao Huang et al. Molecular Therapy-Oncolytics
- Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents
- (2019) Robert H. Whitaker et al. Cells
- Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents
- (2019) Jin Qian et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds
- (2019) Marco Tagliamento et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- 3-acetyl-11-keto-beta-boswellic acid decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance (MDR) proteins function
- (2019) Lu Jin et al. BIOMEDICINE & PHARMACOTHERAPY
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018)
- (2019) Kashif Haider et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP
- (2019) Hongna Lai et al. Science China-Life Sciences
- Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects
- (2019) Pascale Barbier et al. Frontiers in Aging Neuroscience
- What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
- (2019) Benedict C. Albensi Frontiers in Cell and Developmental Biology
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression
- (2019) Dan Liao et al. MOLECULES
- Current trends in drug metabolism and pharmacokinetics
- (2019) Yuhua Li et al. Acta Pharmaceutica Sinica B
- A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery
- (2019) Uttpal Anand et al. Metabolites
- 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells
- (2019) Zhaoshi Bai et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
- (2019) Joanna Kopecka et al. DRUG RESISTANCE UPDATES
- Advanced technological tools to study multidrug resistance in cancer
- (2019) Luca Andrei et al. DRUG RESISTANCE UPDATES
- Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
- (2019) Silpa Narayanan et al. DRUG RESISTANCE UPDATES
- Plant derived anticancer agents: A green approach towards skin cancers
- (2018) Shakeel Ijaz et al. BIOMEDICINE & PHARMACOTHERAPY
- Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
- (2018) Rochanawan Sootichote et al. BMC CANCER
- Single-cell Transcriptome Analyses Reveal Molecular Signals to Intrinsic and Acquired Paclitaxel Resistance in Esophageal Squamous Cancer Cells
- (2018) Hongjin Wu et al. CANCER LETTERS
- Dendrimers in combination with natural products and analogues as anti-cancer agents
- (2018) Serge Mignani et al. CHEMICAL SOCIETY REVIEWS
- The challenge of drug resistance in cancer treatment: a current overview
- (2018) Michail Nikolaou et al. CLINICAL & EXPERIMENTAL METASTASIS
- Paclitaxel Sensitivity of Ovarian Cancer can be enhanced by knocking down Pairs of Kinases that regulate MAP4 Phosphorylation and Microtubule Stability
- (2018) Hailing Yang et al. CLINICAL CANCER RESEARCH
- The Bioavailability, Transport, and Bioactivity of Dietary Flavonoids: A Review from a Historical Perspective
- (2018) Gary Williamson et al. COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY
- Microtubule dynamics: moving toward a multi-scale approach
- (2018) Mahya Hemmat et al. CURRENT OPINION IN CELL BIOLOGY
- Apoptosis: A Target for Anticancer Therapy
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phytochylomicron as a dual nanocarrier for liver cancer targeting of luteolin: in vitro appraisal and pharmacodynamics
- (2018) Yosra SR Elnaggar et al. Nanomedicine
- Concomitant Delivery of Paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy
- (2018) Dikshi Gupta et al. Nanomedicine-Nanotechnology Biology and Medicine
- Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models
- (2018) Manal A. Elsheikh et al. PHARMACEUTICAL RESEARCH
- Microtubules and Microtubule-Associated Proteins
- (2018) Holly V. Goodson et al. Cold Spring Harbor Perspectives in Biology
- Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling
- (2018) Ying-Ya Cao et al. Cell Death & Disease
- Targeting BCL-2 regulated apoptosis in cancer
- (2018) Kirsteen J. Campbell et al. Open Biology
- Bio-inspired drug delivery systems: an emerging platform for targeted cancer therapy
- (2018) Gella Maelys Ngandeu Neubi et al. Biomaterials Science
- Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1α
- (2018) Jiang Qian et al. Biomed Research International
- Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
- (2018) Kulmira Nurgali et al. Frontiers in Pharmacology
- The hypoxic tumour microenvironment
- (2018) Varvara Petrova et al. Oncogenesis
- Soluble resistance-related calcium-binding protein in cancers
- (2018) Xiao Yu et al. CLINICA CHIMICA ACTA
- Tariquidar-Related Chalcones and Ketones as ABCG2 Modulators
- (2018) Diana Peña-Solórzano et al. ACS Medicinal Chemistry Letters
- Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells
- (2018) Jie Ding et al. Biomed Research International
- Curcumin inhibits proliferation, migration, invasion and promotes apoptosis of retinoblastoma cell lines through modulation of miR-99a and JAK/STAT pathway
- (2018) Yaping Li et al. BMC CANCER
- Modulating ROS to overcome multidrug resistance in cancer
- (2018) Qingbin Cui et al. DRUG RESISTANCE UPDATES
- Structural insight into microtubule stabilization and kinesin inhibition by Tau family MAPs
- (2018) Hideki Shigematsu et al. JOURNAL OF CELL BIOLOGY
- Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art
- (2018) Sally A. El-Zahaby et al. JOURNAL OF CONTROLLED RELEASE
- Elaboration of polymersomes versus conventional liposomes for improving oral bioavailability of the anticancer flutamide
- (2018) Shams F Youssef et al. Nanomedicine
- Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents
- (2018) Maricruz Anaya-Ruiz et al. Recent Patents on Anti-Cancer Drug Discovery
- Structural basis of tubulin recruitment and assembly by microtubule polymerases with tumor overexpressed gene (TOG) domain arrays
- (2018) Stanley Nithianantham et al. eLife
- DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells
- (2017) Ana Podolski-Renić et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Tubulin Post-Translational Modifications and Microtubule Dynamics
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Essential Roles of E3 Ubiquitin Ligases in p53 Regulation
- (2017) Sanam Sane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Taxol®: The First Microtubule Stabilizing Agent
- (2017) Chia-Ping Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Paclitaxel: What has been done and the challenges remain ahead
- (2017) Ezequiel Bernabeu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The tubulin code at a glance
- (2017) Sudarshan Gadadhar et al. JOURNAL OF CELL SCIENCE
- Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
- (2017) Deepali Waghray et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploring the effect of end-binding proteins and microtubule targeting chemotherapy drugs on microtubule dynamic instability
- (2017) Diana White et al. JOURNAL OF THEORETICAL BIOLOGY
- Inhibitory effect of Shenqi Fuzheng injection combined with docetaxel on lung cancer cells
- (2017) Bo-yu Dong et al. Journal of Zhejiang University-SCIENCE B
- The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors
- (2017) Hui Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Ginger Phytochemicals Inhibit Cell Growth and Modulate Drug Resistance Factors in Docetaxel Resistant Prostate Cancer Cell
- (2017) Chi-Ming Liu et al. MOLECULES
- Self-emulsifying preconcentrates of daidzein–phospholipid complex: design, in vitro and in vivo appraisal
- (2017) Yosra SR Elnaggar et al. Nanomedicine
- Phosphorylation of Bcl-2 plays an important role in glycochenodeoxycholate-induced survival and chemoresistance in HCC
- (2017) Maojun Zhou et al. ONCOLOGY REPORTS
- Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationships
- (2017) Sonthaya Umsumarng et al. PHYTOMEDICINE
- Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development
- (2017) Karine A. Cohen-Solal et al. Pigment Cell & Melanoma Research
- Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
- (2017) Guan-Zhong Qiu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- RSF1 regulates the proliferation and paclitaxel resistance via modulating NF-κB signaling pathway in nasopharyngeal carcinoma
- (2017) Yong Liu et al. Journal of Cancer
- Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells
- (2017) Jinming Zhang et al. Scientific Reports
- Transcription Factor NF-κB: An Update on Intervention Strategies
- (2016) Arvind Panday et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel
- (2016) Sayaka Sobue et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An evolutionary roadmap to the microtubule-associated protein MAP Tau
- (2016) Frederik Sündermann et al. BMC GENOMICS
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Lysosomes as mediators of drug resistance in cancer
- (2016) Benny Zhitomirsky et al. DRUG RESISTANCE UPDATES
- Mitotic catastrophe and cancer drug resistance: A link that must to be broken
- (2016) Tatiana V. Denisenko et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells
- (2016) Kuan-Chun Huang et al. EUROPEAN JOURNAL OF CANCER
- A novel solubilization technique for poorly soluble drugs through the integration of nanocrystal and cocrystal technologies
- (2016) Masatoshi Karashima et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines
- (2016) Ganesan Muthusamy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The structural modification of natural products for novel drug discovery
- (2016) Hong Yao et al. Expert Opinion on Drug Discovery
- Self-emulsifying phospholipid pre-concentrates (SEPPs) for improved oral delivery of the anti-cancer genistein: Development, appraisal and ex-vivo intestinal permeation
- (2016) Eman M.M. Shehata et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account
- (2016) Roberto Collado-Borrell et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles
- (2016) Wanting Zou et al. JOURNAL OF DRUG TARGETING
- Cardiac Glycoside Constituents of Streblus asper with Potential Antineoplastic Activity
- (2016) Yulin Ren et al. JOURNAL OF NATURAL PRODUCTS
- Natural Products as Sources of New Drugs from 1981 to 2014
- (2016) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform
- (2016) Y. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Remodeling of the Extracellular Matrix by Endothelial Cell-Targeting siRNA Improves the EPR-Based Delivery of 100 nm Particles
- (2016) Yu Sakurai et al. MOLECULAR THERAPY
- Jatrophane diterpenes and cancer multidrug resistance – ABCB1 efflux modulation and selective cell death induction
- (2016) Mariana Alves Reis et al. PHYTOMEDICINE
- Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer
- (2016) Weiwei Wang et al. PROTOPLASMA
- Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines
- (2016) Edna Ooko et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms
- (2016) L Wang et al. Cell Death & Disease
- Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis
- (2016) Rong Biaoxue et al. Oncotarget
- β-casein nanovehicles for oral delivery of chemotherapeutic drug combinations overcoming P-glycoprotein-mediated multidrug resistance in human gastric cancer cells
- (2016) Maya Bar-Zeev et al. Oncotarget
- p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells
- (2016) Shin-Hyung Park et al. Oncotarget
- Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics
- (2016) Gan Lin et al. Advanced Science
- Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
- (2016) Jie Meng et al. Scientific Reports
- Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids
- (2015) Maen Zeino et al. BIOCHEMICAL PHARMACOLOGY
- Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance
- (2015) Jezrael L. Revalde et al. BIOCHEMICAL PHARMACOLOGY
- Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
- (2015) Khalid O Alfarouk et al. Cancer Cell International
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Taxane anticancer agents: a patent perspective
- (2015) Iwao Ojima et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis
- (2015) Xiaoqian Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles
- (2015) Jong-Suep Baek et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Improving drug delivery to solid tumors: Priming the tumor microenvironment
- (2015) Iftikhar Ali Khawar et al. JOURNAL OF CONTROLLED RELEASE
- The re-emergence of natural products for drug discovery in the genomics era
- (2015) Alan L. Harvey et al. NATURE REVIEWS DRUG DISCOVERY
- Control of microtubule organization and dynamics: two ends in the limelight
- (2015) Anna Akhmanova et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Deceivingly dynamic: Learning-dependent changes in stathmin and microtubules
- (2015) Shusaku Uchida et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- The role of photodynamic therapy in overcoming cancer drug resistance
- (2015) Bryan Q. Spring et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Stathmin Potentiates Vinflunine and Inhibits Paclitaxel Activity
- (2015) Soazig Malesinski et al. PLoS One
- Post-translational modifications of tubulin: pathways to functional diversity of microtubules
- (2015) Yuyu Song et al. TRENDS IN CELL BIOLOGY
- Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer
- (2015) Dong-Hoe Koo et al. TUMOR BIOLOGY
- Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer
- (2015) Ruifang Sun et al. TUMOR BIOLOGY
- Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer
- (2015) Yingqian Lv et al. OncoTargets and Therapy
- Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy
- (2015) Anna Barbuti et al. Cancers
- Bcl-2—Enhanced Efficacy of Microtubule-Targeting Chemotherapy through Bim Overexpression: Implications for Cancer Treatment
- (2015) Amandine Savry et al. NEOPLASIA
- Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances
- (2014) Ruth Matesanz et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway
- (2014) Ting Chen et al. CANCER BIOLOGY & THERAPY
- High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
- (2014) Gregory M. Alushin et al. CELL
- Plant natural products: from traditional compounds to new emerging drugs in cancer therapy
- (2014) L. Ouyang et al. CELL PROLIFERATION
- Post-translational modifications of tubulin
- (2014) Maria M. Magiera et al. CURRENT BIOLOGY
- A novel approach to overcome multidrug resistance: Utilization of P-gp mediated efflux of paclitaxel to attack neighboring vascular endothelial cells in tumors
- (2014) Yuta Yoshizawa et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cancer active targeting by nanoparticles: a comprehensive review of literature
- (2014) Remon Bazak et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Marine Natural Products with P-Glycoprotein Inhibitor Properties
- (2014) Dioxelis Lopez et al. Marine Drugs
- The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin
- (2014) Wenting He et al. MEDICAL ONCOLOGY
- Targeting Microtubules by Natural Agents for Cancer Therapy
- (2014) E. Mukhtar et al. MOLECULAR CANCER THERAPEUTICS
- Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway
- (2014) Jiangxia Cai et al. PHYTOMEDICINE
- Psoralen reverses docetaxel-induced multidrug resistance in A549/D16 human lung cancer cells lines
- (2014) Ming-Ju Hsieh et al. PHYTOMEDICINE
- Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2
- (2014) Jiangxia Cai et al. PHYTOMEDICINE
- Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer
- (2014) Henrica M. J. Werner et al. PLoS One
- Many players in BCL-2 family affairs
- (2014) Tudor Moldoveanu et al. TRENDS IN BIOCHEMICAL SCIENCES
- The role of ABC transporters in anticancer drug transport
- (2014) Serhan KARVAR TURKISH JOURNAL OF BIOLOGY
- Saikosaponin A ve Saikosaponin D ile MCF-7/Pac Hücre Hattında Paklitaksel Dirençliliğinin Engellenmesi
- (2014) Meltem Kars UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi
- Rationally designed nanovehicles to overcome cancer chemoresistance
- (2013) Yoav D. Livney et al. ADVANCED DRUG DELIVERY REVIEWS
- Natural products: A continuing source of novel drug leads
- (2013) Gordon M. Cragg et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The role of ubiquitin modification in the regulation of p53
- (2013) Andreas K. Hock et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Different strategies to overcome multidrug resistance in cancer
- (2013) Manju Saraswathy et al. BIOTECHNOLOGY ADVANCES
- Overcoming Paclitaxel Resistance in Lung Cancer Cells Via Dual Inhibition of Stathmin and Bcl-2
- (2013) Zheng-Xiang Han et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
- (2013) Ziyad Binkhathlan et al. CURRENT CANCER DRUG TARGETS
- Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers
- (2013) Swati Dawar et al. DRUG DISCOVERY TODAY
- BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells
- (2013) Ayano Watanabe et al. EXPERIMENTAL DERMATOLOGY
- Cancer Development, Progression, and Therapy: An Epigenetic Overview
- (2013) Sibaji Sarkar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome–microbubble complexes assisted by ultrasound
- (2013) Zhiting Deng et al. JOURNAL OF CONTROLLED RELEASE
- Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy
- (2013) Marta Smoter et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Signal Transduction Pathways and Transcriptional Mechanisms of ABCB1/Pgp-mediated Multiple Drug Resistance in Human Cancer Cells
- (2013) H Sui et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
- (2013) A. E. Prota et al. SCIENCE
- Death Receptor-Ligand Systems in Cancer, Cell Death, and Inflammation
- (2013) H. Walczak Cold Spring Harbor Perspectives in Biology
- Mechanisms of Action of Bcl-2 Family Proteins
- (2013) A. Shamas-Din et al. Cold Spring Harbor Perspectives in Biology
- miR-21 modulates paclitaxel sensitivity and hypoxia-inducible factor-1α expression in human ovarian cancer cells
- (2013) ZHONGBIN XIE et al. Oncology Letters
- A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells
- (2013) Yong Wu et al. CELLULAR ONCOLOGY
- New Insight into P-Glycoprotein as a Drug Target
- (2012) Albert Breier et al. Anti-Cancer Agents in Medicinal Chemistry
- p53 acetylation enhances Taxol-induced apoptosis in human cancer cells
- (2012) Jae Hyeong Kim et al. APOPTOSIS
- Effects of Kampo Medicines on MDR-1-Mediated Multidrug Resistance in Human Hepatocellular Carcinoma HuH-7/PTX Cells
- (2012) Sumiko Hyuga et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Overview of P-glycoprotein inhibitors: a rational outlook
- (2012) Kale Mohana Raghava Srivalli et al. Brazilian Journal of Pharmaceutical Sciences
- Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway
- (2012) Yeong-In Yang et al. CARCINOGENESIS
- PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells
- (2012) Can Sarisozen et al. DRUG DELIVERY
- Characterization of flavonoids from Dryopteris erythrosora and evaluation of their antioxidant, anticancer and acetylcholinesterase inhibition activities
- (2012) Jianguo Cao et al. FOOD AND CHEMICAL TOXICOLOGY
- Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
- (2012) S. P. Glaser et al. GENES & DEVELOPMENT
- Nanotechnology applied to overcome tumor drug resistance
- (2012) Zibin Gao et al. JOURNAL OF CONTROLLED RELEASE
- Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells
- (2012) Masanobu Tsubaki et al. LEUKEMIA RESEARCH
- High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non-Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
- (2012) G. Levallet et al. MOLECULAR CANCER THERAPEUTICS
- Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters
- (2012) Safaa Yehia Eid et al. PHYTOMEDICINE
- Up-regulation of P-glycoprotein is involved in the increased paclitaxel resistance in human esophageal cancer radioresistant cells
- (2012) Yan Wang et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Autophagy and Transporter-Based Multi-Drug Resistance
- (2012) Priyank Kumar et al. Cells
- Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1
- (2011) X.L. Dong et al. BIOMEDICINE & PHARMACOTHERAPY
- Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer
- (2011) Min Han Tan et al. BREAST CANCER RESEARCH AND TREATMENT
- miRNA-34a is associated with docetaxel resistance in human breast cancer cells
- (2011) L. Kastl et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of Tau protein in resistance to paclitaxel
- (2011) Marta Smoter et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- YHHU0895, a novel synthetic small-molecule microtubule-destabilizing agent, effectively overcomes P-glycoprotein-mediated tumor multidrug resistance
- (2011) Hongbing Zhao et al. CANCER LETTERS
- Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2011) Yue Wang et al. CYTOKINE
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes
- (2011) Niravkumar R. Patel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The Determinants That Govern Microtubule Assembly from the Atomic Structure of GTP-Tubulin
- (2011) Agata Nawrotek et al. JOURNAL OF MOLECULAR BIOLOGY
- Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression
- (2011) Stefania Nobili et al. MEDICINAL RESEARCH REVIEWS
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
- (2011) Hiroyuki Inuzuka et al. NATURE
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- (2011) Ingrid E. Wertz et al. NATURE
- Reversal of multidrug resistance in human breast cancer cells by Curcuma wenyujin and Chrysanthemum indicum
- (2011) L. Yang et al. PHYTOMEDICINE
- Role of p53 in Cell Death and Human Cancers
- (2011) Toshinori Ozaki et al. Cancers
- Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters
- (2010) Y.-j. Mi et al. CANCER RESEARCH
- Class III -Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy
- (2010) G. Ploussard et al. CANCER RESEARCH
- Tumoral and tissue-specific expression of the major human β-tubulin isotypes
- (2010) Luis J. Leandro-García et al. Cytoskeleton
- Effect of Thai Plant Extracts on P-glycoprotein Function and Viability in Paclitaxel-Resistant HepG2 Cells
- (2010) Masashi Kawami et al. Drug Metabolism and Pharmacokinetics
- Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy
- (2010) Gur Pines et al. FEBS LETTERS
- Human Mutations That Confer Paclitaxel Resistance
- (2010) S. Yin et al. MOLECULAR CANCER THERAPEUTICS
- Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines
- (2010) H Zhang et al. ONCOGENE
- Structure–Activity Relationships of Tariquidar Analogs as Multidrug Resistance Modulators
- (2009) Ilza K. Pajeva et al. AAPS Journal
- The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance
- (2009) Yogesh B. Patil et al. BIOMATERIALS
- Class III β-tubulin expression and in vitro resistance to microtubule targeting agents
- (2009) C Stengel et al. BRITISH JOURNAL OF CANCER
- Kinesin motor proteins as targets for cancer therapy
- (2009) Dennis Huszar et al. CANCER AND METASTASIS REVIEWS
- A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen
- (2009) Paul Ruff et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Overexpression of Kinesins Mediates Docetaxel Resistance in Breast Cancer Cells
- (2009) S. De et al. CANCER RESEARCH
- Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1α
- (2009) Lei Huang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Microtubule-associated protein tau in human prostate cancer cells: Isoforms, phosphorylation, and interactions
- (2009) Skye Souter et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance
- (2008) Ying Zhou et al. BIOCHEMICAL PHARMACOLOGY
- A Short Nur77-Derived Peptide Converts Bcl-2 from a Protector to a Killer
- (2008) Siva Kumar Kolluri et al. CANCER CELL
- Inducing apoptosis and enhancing chemosensitivity to Gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell
- (2008) San-Hua Wei et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Alteration of the Mitochondrial Apoptotic Pathway Is Key to Acquired Paclitaxel Resistance and Can Be Reversed by ABT-737
- (2008) O. Kutuk et al. CANCER RESEARCH
- The epidermal growth factor receptor family: Biology driving targeted therapeutics
- (2008) M. J. Wieduwilt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges
- (2008) Suneet Shukla et al. Expert Opinion on Drug Metabolism & Toxicology
- Microtubules: A dynamic target in cancer therapy
- (2008) Eddy Pasquier et al. IUBMB LIFE
- Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer
- (2008) Catherine Lhommé et al. JOURNAL OF CLINICAL ONCOLOGY
- Taxanes from Shells and Leaves ofCorylus avellana
- (2007) Laura Ottaggio et al. JOURNAL OF NATURAL PRODUCTS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started